Jeff Caravella
Geen lopende functies
Vermogen: - $ op 31-03-2024
Profiel
Jeff Caravella served as the Chief Financial Officer at BioTheryX, Inc. and Medicenna Therapeutics Corp.
He received an undergraduate degree and an MBA from Syracuse University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 28-09-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Eerdere bekende functies van Jeff Caravella
| Bedrijven | Functie | Einde |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Director of Finance/CFO | 26-10-2023 |
BioTheryX, Inc.
 BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Director of Finance/CFO | - |
Opleiding van Jeff Caravella
| Syracuse University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MEDICENNA THERAPEUTICS CORP. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Health Technology |
